“Lymphangiomatosis” is a general term for excessive growth of aberrant lymphatic vessels. The impact of lymphangiomatosis can be devastating due to osteolysis and/or multi-organ involvement. The disorders are heterogeneous, and treatment is dependent upon disease location and symptoms. Most reports are single cases or small case series, predominantly in the orthopedic and radiologic literature. Basic research focused on lymphatic disorders may translate into new therapies for these disorders.
Get full access to this article
View all access options for this article.
References
1.
GorhamLW. Circulatory changes associated with osteolytic and osteoblastic reactions in bone. The possible mechanism involved in massive osteolysis: An experimental study. Arch Intern Med, 1960; 105:199–216.
LangerJC, FitzgeraldPG, DesaDet al.Cervical cystic hygroma in the fetus: Clinical spectrum and outcome. J Pediatr Surg, 1990; 25:58–61discussion 61–52.
4.
TamayZ, SaribeyogluE, OnesUet al.Diffuse thoracic lymphangiomatosis with disseminated intravascular coagulation in a child. J Pediatr Hematol Oncol, 2005; 27:685–687.
5.
GirishaKM, GaneshHK, RaoL, SrilathaPS. Massive cranial osteolysis, skin changes, growth retardation and developmental delay: Gorham syndrome with systemic manifestations?Am J Med Genet A, 2010; 152A:759–763.
6.
EscandeC, SchoumanT, FrancoiseGet al.Histological features and management of a mandibular Gorham disease: A case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008; 106:e30–37.
7.
BurgessS, HarrisM, DakinC, BorziP, RyanC, CooperD. Successful management of lymphangiomatosis and chylothorax in a 7-month-old infant. J Paediatr Child Health, 2006; 42:560–562.
8.
BalakrishnanR, MajeskyM, PerkinsJ. Head and neck lymphatic tumors and bony abnormalities: A clinical and molecular Review. Lymphat Res Biol, 2011; 9:185–192.
9.
GorhamLW, StoutAP. Hemangiomatosis and its relation to massive osteolysis. Trans Assoc Am Physicians, 1954; 67:302–307.
10.
GiammalvoJT. Congenital lymphangiomatosis of the lung: A form of cystic disease; Report of a case with autopsy findings. Lab Invest, 1955; 4:450–456.
11.
VenkatramaniR, MaNS, PitukcheewanontP, MalogolowkinMH, MascarenhasL. Gorham's disease and diffuse lymphangiomatosis in children and adolescents. Pediatr Blood Cancer, 2011; 56:667–670.
12.
GorhamLW, WrightAW, ShultzHH, MaxonFCJr. Disappearing bones: A rare form of massive osteolysis; Report of two cases, one with autopsy findings. Am J Med, 1954; 17:674–682.
13.
AschMJ, CohenAH, MooreTC. Hepatic and splenic lymphangiomatosis with skeletal involvement: Report of a case and review of the literature. Surgery, 1974; 76:334–339.
14.
LeeS, FinnL, SzeRW, PerkinsJA, SieKC. Gorham Stout syndrome (disappearing bone disease): Two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg, 2003; 129:1340–1343.
15.
PflegerA, SchwingerW, MaierA, TaussJ, PopperHH, ZachMS. Gorham-Stout syndrome in a male adolescent. Case report and review of the literature. J Pediatr Hematol Oncol, 2006; 28:231–233.
16.
AvivRI, McHughK, HuntJ. Angiomatosis of bone and soft tissue: A spectrum of disease from diffuse lymphangiomatosis to vanishing bone disease in young patients. Clin Radiol, 2001; 56:184–190.
17.
GondivkarSM, GadbailAR. Gorham-Stout syndrome: A rare clinical entity and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010; 109:e41–48.
18.
RuggieriP, MontaltiM, AngeliniA, AlberghiniM, MercuriM. Gorham-Stout disease: The experience of the Rizzoli Institute and review of the literature. Skeletal Radiol, 2011; 40:1391–1397.
RauhG, GrossM. Disappearing bone disease (Gorham-Stout disease): Report of a case with a follow-up of 48 years. Eur J Med Res, 1997; 2:425–427.
21.
RubelIF, CarrerA, GillesJJ, HowardR, CohenG. Progressive Gorham disease of the forearm. Orthopedics, 2008; 31:284.
22.
ChattopadhyayP, BandyopadhyayA, DasS, KunduAJ. Gorham's disease with spontaneous recovery. Singapore Med J, 2009; 50:e259–263.
23.
KristofAS. mTOR signaling in lymphangioleiomyomatosis. Lymphat Res Biol Mar, 2010; 8,1:33–42.
24.
CasanovaA, AncocheaJ. Lymphangioleiomyomatosis: New therapeutic approaches. Arch Bronconeumol, 2011; 47:579–580.
25.
McCormackFX, InoueY, MossJet al.Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med, 2011; 364:1595–1606.
26.
PimentaSP, BaldiBG, AcencioMM, KairallaRA, CarvalhoCR. Doxycycline use in patients with lymphangioleiomyomatosis: Safety and efficacy in metalloproteinase blockade. J Bras Pneumol, 2011; 37:424–430.
27.
ChungC, YuJS, ResnickD, VaughanLM, HaghighiP. Gorham syndrome of the thorax and cervical spine: CT and MRI findings. Skeletal Radiol, 1997; 26:55–59.
28.
SpiethME, GreenspanA, ForresterDM, AnsariAN, KimuraRL, Gleason-JordanI. Gorham's disease of the radius: Radiographic, scintigraphic, and MRI findings with pathologic correlation. A case report and review of the literature. Skeletal Radiol, 1997; 26:659–663.
29.
ManisaliM, OzaksoyD. Gorham disease: Correlation of MR findings with histopathologic changes. Eur Radiol, 1998; 8:1647–1650.
WimsattJ, WithrowSJ, DannerD, PowersB, HaglerT, PritzkerKP. Multicystic bone disease (Gorham-Stout syndrome) in a spider monkey (Ateles geoffroyi)J Med Primatol, 2011; 40:61–70.
37.
YanagawaT, WatanabeH, ShinozakiT, AhmedAR, ShirakuraK, TakagishiK. The natural history of disappearing bone tumours and tumour-like conditions. Clin Radiol, 2001; 56:877–886.
38.
RouzierC, VanatkaR, BannwarthSet al.A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet, 2006; 69:271–276.
39.
EllisonDA, EllisEN, KokoskaER. Hajdu-Cheney syndrome: Report of a case. Pediatr Dev Pathol, 2007; 10:470–476.
40.
Al KaissiA, Scholl-BuergiS, BiedermannRet al.The diagnosis and management of patients with idiopathic osteolysis. Pediatr Rheumatol Online J, 2011; 9:31.
41.
JeaA, McNeilA, BhatiaSet al.A rare case of lymphangiomatosis of the craniocervical spine in conjunction with a Chiari I malformation. Pediatr Neurosurg, 2003; 39:212–215.
42.
HughesBD, GrantGA, CummingsTJ, FuchsHE. Disappearing bone disease and Chiari I malformation. Pediatr Neurosurg, 2010; 46:58–61.
43.
AdlerF, GuptaN, HessCP, DowdCF, DillonWP. Intraosseous CSF fistula in a patient with Gorham disease resulting in intracranial hypotension. AJNR Am J Neuroradiol, 2011June9, 2011[Epub ahead of print].
44.
MollerG, PriemelM, AmlingM, WernerM, KuhlmeyAS, DellingG. The Gorham-Stout syndrome (Gorham's massive osteolysis). A report of six cases with histopathological findings. J Bone Joint Surg Br, 1999; 81:501–506.
45.
MignognaMD, FedeleS, Lo RussoL, CiccarelliR. Treatment of Gorham's disease with zoledronic acid. Oral Oncol, 2005; 41:747–750.
46.
HammerF, KennW, WesselmannUet al.Gorham-Stout disease—Stabilization during bisphosphonate treatment. J Bone Miner Res, 2005; 20:350–353.
47.
HeydR, RabeneckD, DornenburgO, TselisN, ZamboglouN. Gorham-Stout syndrome of the pelvic girdle treated by radiation therapy: A case report. Strahlenther Onkol, 2011; 187:140–143.
48.
LehmannG, PfeilA, BottcherJet al.Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg, 2009; 129:967–972.
49.
AvelarRL, MartinsVB, AntunesAA, de Oliveira NetoPJ, AndradeES. Use of zoledronic acid in the treatment of Gorham's disease. Int J Pediatr Otorhinolaryngol, 2010; 74:319–322.
50.
SunS, LiuX, MaB, ZhouY, SunH. Could local deliver of bisphosphonates be a new therapeutic choice for Gorham-Stout syndrome?Med Hypotheses, 2011; 76:237–238.
51.
BrodszkiN, LansbergJK, DictorMet al.A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr, 2011.
52.
GrunewaldTG, DamkeL, MaschanMet al.First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol, 2010; 21:1733–1734.
53.
OzekiM, FukaoT, KondoN. Propranolol for intractable diffuse lymphangiomatosis. N Engl J Med, 2011; 364:1380–1382.
54.
DajeeH, WoodhouseR. Lymphangiomatosis of the mediastinum with chylothorax and chylopericardium: Role of radiation treatment. J Thorac Cardiovasc Surg, 1994; 108:594–595.
55.
AokiM, KatoF, SaitoH, MimatsuK, IwataH. Successful treatment of chylothorax by bleomycin for Gorham's disease. Clin Orthop Relat Res, 1996; 330:193–197.
56.
GuvencBH, EkingenG, TuzlaciA, SenelU. Diffuse neonatal abdominal lymphangiomatosis: Management by limited surgical excision and sclerotherapy. Pediatr Surg Int, 2005; 21:595–598.
57.
PaleyMD, LloydCJ, PenfoldCN. Total mandibular reconstruction for massive osteolysis of the mandible (Gorham-Stout syndrome)Br J Oral Maxillofac Surg, 2005; 43:166–168.
58.
ChalidisBE, DimitriouCG. Intercalary bone grafting for the reconstruction of phalangeal osteolysis in disappearing bone disease: Case report. J Hand Surg Am, 2008; 33:1873–1877.
59.
SteinacherI, LamprechtB, LobendanzMet al.Successful surgical treatment of thoracic multiorgan lymphangiomatosis. Wien Klin Wochenschr, 2009; 121:644–647.
60.
BrowneJA, ShivesTC, TrousdaleRT. Thirty-year follow-up of patient with Gorham disease (massive osteolysis) treated with hip arthroplasty. J Arthroplasty, 2011; 26:339e337–310.
61.
RuggieriP, MavrogenisAF, GuerraG, MercuriM. Preliminary results after reconstruction of bony defects of the proximal humerus with an allograft-resurfacing composite. J Bone Joint Surg Br, 2011; 93:1098–1103.
62.
TanCA, ChenPJ, LiuTK, ShenPW. Chylous hip joint effusion and bone absorption after total hip arthroplasty in a patient with chylocolporrhoea: A case of Gorham's disease. Hip Int, 2011; 21:378–382.
63.
KinnierCV, EuJP, DavisRD, HowellDN, SheetsJ, PalmerSM. Successful bilateral lung transplantation for lymphangiomatosis. Am J Transplant, 2008; 8:1946–1950.
KandilA, RostomAY, MouradWA, KhafagaY, GershunyAR, el-HosseinyG. Successful control of extensive thoracic lymphangiomatosis by irradiation. Clin Oncol (R Coll Radiol), 1997; 9:407–411.
69.
FontanesiJ. Radiation therapy in the treatment of Gorham disease. J Pediatr Hematol Oncol, 2003; 25:816–817.
70.
DuffyBM, ManonR, PatelRR, WelshJS. A case of Gorham's disease with chylothorax treated curatively with radiation therapy. Clin Med Res, 2005; 3:83–86.
71.
SkidmoreTB, LeeCM, AbbottTMet al.Gorham disease of the mandible: Radiographic findings and radiotherapy response. Ear Nose Throat J, 2008; 87:E4–7.
72.
HirayamaT, SabokbarA, ItonagaI, Watt-SmithS, AthanasouNA. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol, 2001; 195:624–630.
73.
MertschingH, WallesT, BakkerG, WildfangI, MacchiariniP. Expression of epidermal growth-factor receptor in lymphangiomatosis: A new therapeutic target?Lancet Oncol, 2004; 5:353.
74.
ReuterS, PrasadS, PhromnoiK, KannappanR, YadavVR, AggarwalBB. Embelin suppresses osteoclastogenesis induced by receptor activator of NF-kappaB ligand and tumor cells in vitro through inhibition of the NF-kappaB cell signaling pathway. Mol Cancer Res, 2010; 8:1425–1436.
75.
YangJC, BaiL, YapS, GaoAC, KungHJ, EvansCP. Effect of the specific Src family kinase inhibitor saracatinib on osteolytic lesions using the PC-3 bone model. Mol Cancer Ther, 2010; 9:1629–1637.
76.
DevlinRD, BoneHG3rd, RoodmanGD. Interleukin-6: A potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab, 1996; 81:1893–1897.
77.
ShiraziF, CohenC, FriedL, ArbiserJL. Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo. Lymphat Res Biol, 2007; 5:233–236.
78.
WiltingJ, ButtlerK, RosslerJet al.Embryonic development and malformation of lymphatic vessels. Novartis Found Symp, 2007; 283:220–227discussion 227–229, 238–241.
